
Glimedom M2 Tablets by Kivonyx Healthcare Pvt. Ltd. contain Glimepiride and Metformin Hydrochloride Prolonged Release, a prescription anti-diabetic combination used for managing Type 2 Diabetes Mellitus in selected adults. Glimepiride is a sulfonylurea that stimulates insulin secretion from pancreatic beta cells, while Metformin reduces glucose production by the liver and improves insulin sensitivity. Glimedom M2 may be prescribed when combination therapy is clinically appropriate for improving fasting and post-meal blood glucose control. Its prolonged-release formulation is designed to release Metformin gradually according to verified product specifications. Available in blister strip packaging, Glimedom M2 should be taken according to a registered medical practitioner's prescription, considering kidney function, hypoglycaemia risk, verified ingredient strengths, dietary habits, and recommended treatment instructions.
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Kivonyx Healthcare Pvt. Ltd. is a leading pharmaceutical company in Ahmedabad, with a primary focus on providing high-quality healthcare products to its clients and customers that cater to a diverse range of health disorders. We are deeply committed to offering innovative healthcare solutions that improve patients’ health and enhance their quality of life. In everything we do or engage with, the foundation remains the same; i.e. an unwavering dedication to quality and innovation.
All our products are manufactured in WHO GMP-certified facilities. With the backing of a strong network, our product range reaches the entire nation with a well-structured distribution channel. Thus, we are highly reliable as a brand when it comes to taking care of the ever-evolving needs of the healthcare community. We offer a wide range of pharmaceutical products for improving patient care, ranging from antibiotics and antifungal treatments to advanced vitamin supplements.
We believe in continuous improvement through research and development, enabling us to stay at the forefront of medical advancements. By combining state-of-the-art technology with a patient-centric approach, we ensure that our solutions not only meet but exceed the expectations of the healthcare sector.